Filing Details

Accession Number:
0001144204-15-003359
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-22 19:31:15
Reporting Period:
2015-01-21
Filing Date:
2015-01-22
Accepted Time:
2015-01-22 19:31:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133869 Capricor Therapeutics Inc. CAPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261186 J Louis Grasmick C/O Capricor Therapeutics, Inc.
8840 Wilshire Blvd., 2Nd Floor
Beverly Hills CA 90211
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-21 141,924 $3.52 1,039,436 No 4 P Indirect By Nancelou, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Nancelou, Inc.
Footnotes
  1. Nancelou, Inc. entered into a Share Purchase Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which Nancelou, Inc., on January 21, 2015, purchased an aggregate of 141,924 shares of the Issuer's common stock at a purchase price of $3.5230 per share for an aggregate purchase price of approximately US$500,000.
  2. 1,039,436 shares of the Issuer's common stock are beneficially owned by Nancelou, Inc. Louis Grasmick and Nancy Grasmick, husband and wife, own 50% of Nancelou, Inc. as tenants by the entirety, and Grant Grasmick, the son of Louis Grasmick and Nancy Grasmick, owns the remaining 50% of Nancelou, Inc. Therefore, Louis Grasmick, Nancy Grasmick and Grant Grasmick are deemed to have shared voting and dispositive power with respect to the securities of the Issuer beneficially owned by Nancelou, Inc.